Novo Nordisk

NVO | NYSE | 326 Followers
$69.03 +0.76% $0.52
Follow
Overview Metrics Financials
Loading...

Fair Price

$877.40
Undervalued by 86.2%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Novo Nordisk A/S (NVO) is a Danish pharmaceutical company specializing in the development, manufacturing, and sale of medicines for the treatment of diabetes and other endocrine and metabolic disorders. The company is one of the world's leading manufacturers of insulin and insulin-related medications, which are essential for diabetes treatment. Novo Nordisk also offers other pharmaceutical products for the treatment of obesity, hemophilia, and various endocrine disorders. The company emphasizes on research and innovation in the field of diabetes and other endocrine diseases and has long been committed to fighting diabetes and obesity. Novo Nordisk A/S has extensive international operations, and its products are available in more than 170 countries. Shares of Novo Nordisk A/S (NVO) could represent an intriguing investment opportunity for those who believe in the long-term demand for diabetes and metabolic medications.

Feed

1y
Read More

Novo Nordisk $NVO closed the day yesterday with a larger market capitalisation than LVMH, making it Europe's largest public company. Novo's share price rose 1.9 percent to $189.3, giving the company a market capitalization of $423 billion.

Do you have shares of $NVO in your portfolio?
2
Share
Zobrazit další komentáře

I don't have NVO stock in my portfolio, but I am very interested in the company and have been following it from afar :)
Like 0
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade